Clinical Trials
6 trialsNCT02446600 2026-05-04
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00795340 2023-08-22
Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT03278717 2022-09-27
ICON9
University College, London
Phase 3 Unknown
NCT00399035 2016-12-28
HORIZON II
AstraZeneca
Phase 3 Completed
NCT00777153 2016-12-28
REGAL
AstraZeneca
Phase 3 Completed
NCT00532194 2015-09-23
ICON6
Medical Research Council
Phase 3 Unknown